ANNUAL REPORT 2003 Financial Highlights Fiscal Year Ended June 30
ANNUAL REPORT 2003 Financial Highlights Fiscal Year Ended June 30 IN THOUSANDS EXCEPT PER SHARE DATA 2003 2002 2001 Service revenue Clinical Research Services $312,847 $261,727 $240,501 PAREXEL Consulting Group $100,621 $ 97,775 $ 80,796 Medical Marketing Services $ 73,786 $ 64,829 $ 54,277 Perceptive Informatics, Inc. $ 24,800 $ 19,987 $ 11,986 Total service revenue $512,054 $444,318 $387,560 Net income (loss) $ 10,662 $ 13,235 $ (825) Diluted earnings (loss) per share $ 0.42 $ 0.52 $ (0.03) Working capital $134,346 $138,020 $123,488 Total assets $464,237 $407,161 $361,534 Stockholders equity $227,100 $200,077 $177,822 Segment Information Service Revenue Geographic Mix Fiscal Year 2003 Fiscal Year 2003 Perceptive Informatics 5% $24.8m Asia/Pacific 4% $17.8m PCG 20% $100.6m Europe 44% $225.6m CRS 61% $312.9m MMS 14% $73.8m 99 00 01 02 03 Total Service Revenue $512.1m The Americas 52% $268.7m $348.5 $378.2 $387.6 $444.3 $512.1 DEAR SHAREHOLDERS: JOSEF H. VON RICKENBACH Chairman of the Board and Chief Executive Officer The true test of any organization is how well it can execute its on clients to have their new products reach peak sales faster and the business strategy – how well the organization turns ideas into plans, additional complexities of the purchasing process for new drugs as it plans into actions, and actions into accomplishments. Execution is relates to payers, patients, and medical professionals. crucial, because nothing says more about a company’s long-term ability to thrive and deliver profitable growth.
[Show full text]